Arena Pharmaceuticals, Inc. (ARNA): Price and Financial Metrics


Arena Pharmaceuticals, Inc. (ARNA)

Today's Latest Price: $66.47 USD

2.67 (4.18%)

Updated Jul 8 6:55pm

Add ARNA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

ARNA Stock Summary

  • With a price/sales ratio of 569.82, Arena Pharmaceuticals Inc has a higher such ratio than 99.12% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.09 for Arena Pharmaceuticals Inc; that's greater than it is for merely 8.57% of US stocks.
  • As for revenue growth, note that ARNA's revenue has grown -99.31% over the past 12 months; that beats the revenue growth of just 0.52% of US companies in our set.
  • Stocks that are quantitatively similar to ARNA, based on their financial statements, market capitalization, and price volatility, are AUTL, CRNX, ASND, QURE, and FATE.
  • ARNA's SEC filings can be seen here. And to visit Arena Pharmaceuticals Inc's official web site, go to www.arenapharm.com.
ARNA Daily Price Range
ARNA 52-Week Price Range

ARNA Stock Price Chart Technical Analysis Charts


ARNA Price/Volume Stats

Current price $66.47 52-week high $69.75
Prev. close $63.80 52-week low $32.95
Day low $63.67 Volume 553,500
Day high $66.49 Avg. volume 702,556
50-day MA $58.55 Dividend yield N/A
200-day MA $49.69 Market Cap 3.35B

Arena Pharmaceuticals, Inc. (ARNA) Company Bio


Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing drugs to address unmet medical needs. The company was founded in 1997 and is based in San Diego, California.


ARNA Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ARNA Latest Social Stream


Loading social stream, please wait...

View Full ARNA Social Stream

Latest ARNA News From Around the Web

Below are the latest news stories about Arena Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARNA as an investment opportunity.

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 18, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on June 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 80,250 shares of its common stock to 12 new…

PR Newswire | June 18, 2020

Arena Pharmaceuticals Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors

SAN DIEGO, June 15, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the appointment of Dr. Katharine Knobil to the Company's Board of Directors. Dr. Knobil brings more than 20 years of leadership and expertise across a range of areas including global…

PR Newswire | June 15, 2020

Arena Pharmaceuticals Announces R&D Leadership Transition

SAN DIEGO, June 8, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced changes to its research and development leadership team. Effective June 9, 2020, Dr. Preston Klassen will be leaving the Company to pursue an opportunity as Chief Executive Officer of a San…

PR Newswire | June 8, 2020

Edited Transcript of ARNA earnings conference call or presentation 7-May-20 8:30pm GMT

Q1 2020 Arena Pharmaceuticals Inc Earnings Call

Yahoo | June 8, 2020

Hedge Funds Aren’t Done Buying Arena Pharmaceuticals, Inc. (ARNA)

In this article we will check out the progression of hedge fund sentiment towards Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]

Yahoo | June 3, 2020

Read More 'ARNA' Stories Here

ARNA Price Returns

1-mo 6.71%
3-mo N/A
6-mo 43.97%
1-year 9.22%
3-year 261.45%
5-year 54.94%
YTD 46.35%
2019 16.61%
2018 14.66%
2017 139.23%
2016 -25.26%
2015 -45.24%

Continue Researching ARNA

Want to see what other sources are saying about Arena Pharmaceuticals Inc's financials and stock price? Try the links below:

Arena Pharmaceuticals Inc (ARNA) Stock Price | Nasdaq
Arena Pharmaceuticals Inc (ARNA) Stock Quote, History and News - Yahoo Finance
Arena Pharmaceuticals Inc (ARNA) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.057 seconds.